| Factor Information | |
|---|---|
| Data ID | 3115 |
| Factor | correlation between nulliparity and obstetric complications |
| Description | multivariate predictor |
| Biomarker | NA |
| Classification | Z (combined factor - combined factor) |
| Association | |
|---|---|
| Application | risk assessment and prognosis |
| Objective | The primary aim of this study was to determine what risk factors predict sustaining adverse obstetric events in pregnant women with CHD. In addition, a secondary aim was to assess the impact of avoiding Valsalva on obstetrical outcomes, an intervention commonly recommended, but never studied. |
| p Value | 0.0327 |
| OR | 6.2 |
| Conclusion | Although one-third of pregnancies were associated with an adverse obstetric outcome, these events could not be predicted by baseline hemodynamic characteristics. The routine practice of avoiding Valsalva may be associated with high rates of post-partum hemorrhage and 3rd/4th degree lacerations. |
| Risk Factor | risk factor |
| CHD Type | |
|---|---|
| ID | 653 |
| CHD Type | isolated CHD/non-isolated CHD |
| CHD Subtype | ASD/VSD/AVC/PS/PA, RV to PAC/DCRV, VSD/AS/AC/TOF/D-TGA, VSD, PS/ccTGA/SV/EA |
| Reference | |
|---|---|
| PMID | 19411123 |
| Year | 2009 |
| Title | Obstetric outcomes in pregnant women with congenital heart disease |
| Sample | ||
|---|---|---|
| Population | pregnant women | |
| Source | patients' data | |
| Region | Boston,America | |
| Method | logistic regression with chi-square test | |
| Race | American | |
| Disease History | N/A | |
| Treatment History | N/A | |
| Group | N/A(Treatment) | N/A(Control) |
| Number | N/A | N/A |
| Age | N/A | N/A |
| Gender (Male: Female) | N/A | N/A |
| Marker Level | odds ratio=6.2 | N/A |
